Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT04799002
PHASE3
Topotecan and Melphalan for Retinoblastoma
Sponsor: Sun Yat-sen University
View on ClinicalTrials.gov
Summary
The purpose of this study is to evaluate topotecan and melphalan for retinoblastoma patients.
Official title: Choice of Topotecan or Melphalan in Retinoblastoma Patients
Key Details
Gender
All
Age Range
Any - Any
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2021-03-11
Completion Date
2027-12-30
Last Updated
2021-03-16
Healthy Volunteers
No
Conditions
Interventions
DRUG
Topotecan
Topotecan intraocular injection for chemotherapy in retinoblastoma
DRUG
Melphalan
Melphalan intraocular injection for chemotherapy in retinoblastoma
Locations (1)
Sun Yat-sen University
Guangzhou, Guangdong, China